Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The maintenance window for External Test System 1 has now been completed and the system is now available for testing. Contact If you have any questions in regards to this IT-Notice please...
-
NASDAQ OMX Derivatives Markets introduces new strikes from 2013-11-07. For further information concerning this exchange notice please contact Product Management, +46 8 405 69 70, or...
-
The maintenance window for External Test System 4 has now been completed and the system is now available for testing. Contact If you have any questions in regards to this IT-Notice please...
-
The maintenance window for External Test System 4 will be used today 2013-11-06 Maintenance window The maintenance window will run from 06:00 CET to 12:00 CET. During this time External Test...
-
Extra maintenance window for External Test System 1 will be used Thursday 20131107. Maintenance window The maintenance window will run the complete day. During this time External Test System 1...
-
NASDAQ OMX Derivatives Markets introduces new strikes from 2013-11-06. For further information concerning this exchange notice please contact Product Management, +46 8 405 69 70, or...
-
NASDAQ OMX Derivatives Markets introduces new strikes from 2013-11-05. For further information concerning this exchange notice please contact Product Management, +46 8 405 69 70, or...
-
NASDAQ OMX Derivatives Markets introduces new strikes from 2013-11-04. For further information concerning this exchange notice please contact Product Management, +46 8 405 69 70, or...
-
The Extra General Meeting (EGM) of Ixonos Plc (Ixonos) held on October 30, 2013 approved a reverse split whereby five (5) existing shares will be consolidated into one (1) new share. The Ex-date is...
-
The following information is based on a press release from Novo Nordisk A/S (Novo Nordisk) dated October 31, 2013 and may be subject to change. The board of Novo Nordisk has decided on a stock...